AquaMed Technologies, Inc. (72)

Browse by Contract Category

Contracts

Warrant Agency Agreement dated December 27, 2021 by and between NexGel, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on December 27, 2021)
Executive Employment Agreement, dated November 4, 2021 by and between NexGel. Inc. and Adam Levy (Filed With SEC on November 9, 2021)
Form of Lock-Up Agreement, dated September 2, 2021, entered into by the Investors (Filed With SEC on September 8, 2021)
Amendment No. 2, dated April 19, 2019, to Agreement and Plan of Merger (Filed With SEC on April 19, 2019)
License Agreement, dated as of April 13, 2017, by and between Tikun Olam Ltd. and TO Pharmaceuticals USA LLC (Filed With SEC on March 12, 2019)
Master Intercompany Services Agreement, dated as of January 1, 2018, by and among T.O. Global LLC, TO Holding Group LLC, Tikun Olam LLC, TO Pharmaceuticals LLC and Israel Liaison... (Filed With SEC on March 12, 2019)
Assignment and Amended and Restated Lease, dated as of January 25, 2002, by and between 2150 Cabot LLC, Embryo Development Corporation and Hydrogel Design Systems, Inc (Filed With SEC on January 9, 2019)
Underwriter Warrant dated December 27, 2021 issued to Maxim Group LLC (Filed With SEC on December 27, 2021)
Underwriting Agreement dated December 21, 2021 by and between NexGel, Inc. and Maxim Group LLC (Filed With SEC on December 27, 2021)
Third Amendment to the Senior Secured Promissory Note, Warrants, and Securities Purchase Agreement (March 11, 2021) dated December 10, 2021 by and between NexGel. Inc. and Auctus... (Filed With SEC on December 10, 2021)
Form of Underwriters Warrant (Filed With SEC on December 10, 2021)
Form of Warrant Agent Agreement (including form of Common Warrant) (Filed With SEC on December 10, 2021)
Form of Underwriting Agreement (Filed With SEC on December 10, 2021)
Second Amendment to the Senior Secured Promissory Note, Warrants, and Securities Purchase Agreement dated March 11, 2021, dated October 28, 2021, between the Company and Auctus... (Filed With SEC on November 3, 2021)
Form of 12% Senior Secured Promissory Note, dated September 2, 2021, issued to the Investors (Filed With SEC on September 8, 2021)
Form of Registration Rights Agreement, dated September 2, 2021, between the Company and the Investors (Filed With SEC on September 8, 2021)
Form of Subordination Agreement, dated September 2, 2021, between the Company, the Investors and Auctus Fund, LLC (Filed With SEC on September 8, 2021)
Form of Security Agreement, dated September 2, 2021, between the Company and the Investors (Filed With SEC on September 8, 2021)
Form of Securities Purchase Agreement, dated September 2, 2021, between the Company and the Investors (Filed With SEC on September 8, 2021)
Form of Common Stock Purchase Warrant, dated September 2, 2021, issued to the Investors (Filed With SEC on September 8, 2021)
First Amendment to the Senior Secured Promissory Note, Warrants, and Securities Purchase Agreement (March 11, 2021) dated August 13, 2021 by and between NexGel. Inc. and Auctus... (Filed With SEC on August 16, 2021)
Security Agreement, dated March 11, 2021, between the Company and Auctus Fund, LLC (Filed With SEC on March 17, 2021)
Securities Purchase Agreement, dated March 11, 2021, between the Company and Auctus Fund, LLC (Filed With SEC on March 17, 2021)
Second Common Stock Purchase Warrant, dated March 11, 2021, issued to Auctus Fund, LLC (Filed With SEC on March 17, 2021)
First Common Stock Purchase Warrant, dated March 11, 2021, issued to Auctus Fund, LLC (Filed With SEC on March 17, 2021)
12% Senior Secured Promissory Note, dated March 11, 2021, issued to Auctus Fund, LLC (Filed With SEC on March 17, 2021)
Registration Rights Agreement, dated March 11, 2021, between the Company and Auctus Fund, LLC (Filed With SEC on March 17, 2021)
Form of Securities Purchase Agreement (Filed With SEC on March 12, 2021)
Form of Securities Purchase Agreement (Filed With SEC on August 21, 2020)
Membership Interest Purchase Agreement dated May 29, 2020 by and among NexGel, Inc. and the Sellers (Filed With SEC on May 29, 2020)
Form of Securities Purchase Agreement (Filed With SEC on March 27, 2020)
Form of Joinder Agreement to Stock Purchase Agreement (Filed With SEC on November 14, 2019)
Amendment to the Stock Purchase Agreement, dated October 23. 2019, between the Company and the Initial Investors (Filed With SEC on November 14, 2019)
Form of Securities Purchase Agreement (Filed With SEC on September 25, 2019)
AquaMed Technologies, Inc. 2019 Long-Term Incentive Plan (Filed With SEC on September 4, 2019)
Form of Restricted Stock Award Agreement under the AquaMed Technologies, Inc. 2019 Long-Term Incentive Plan (Filed With SEC on September 4, 2019)
Form of Nonqualified Stop Option Agreement under the AquaMed Technologies, Inc. 2019 Long-Term Incentive Plan (Filed With SEC on September 4, 2019)
Form of Bill of Sale and Assignment and Assumption Agreement between Alliqua BioMedical, Inc. and AquaMed Technologies, Inc (Filed With SEC on March 12, 2019)
Warrant, dated November 1, 2018, issued to Bernard Sucher, exercisable at $15.11 per Class A Unit (Filed With SEC on March 12, 2019)
Form of Restricted Stock Award Agreement under 2019 Incentive Plan (Filed With SEC on March 12, 2019)
License Agreement, dated as of April 13, 2017, by and between Tikun Olam Ltd. and Tikun Olam IP Ltd (Filed With SEC on March 12, 2019)
Letter Agreement, dated September 26, 2018, by and between T.O. Global LLC and TO Pharmaceuticals LLC (Filed With SEC on March 12, 2019)
Employment Agreement, dated as of March 9, 2016, by and between TO Pharmaceuticals LLC and Sidney Taubenfeld (Filed With SEC on March 12, 2019)
Management Consulting Agreement dated October 19, 2018 between TO Pharmaceutical LLC and Seth Yakatan (Filed With SEC on March 12, 2019)
Warrant, dated March 9, 2016 issued to Sidney Taubenfeld (Filed With SEC on March 12, 2019)
Warrant, dated November 1, 2018, issued to Bernard Sucher, exercisable at $45.32 per Class A Unit (Filed With SEC on March 12, 2019)
Form of 2019 Incentive Plan (Filed With SEC on March 12, 2019)
Form of Incentive Option Agreement under 2019 Incentive Plan (Filed With SEC on March 12, 2019)
Form of Nonqualified Stock Option Agreement under 2019 Incentive Plan (Filed With SEC on March 12, 2019)
Form of Asset Contribution and Separation Agreement between Alliqua BioMedical, Inc. and AquaMed Technologies, Inc (Filed With SEC on January 9, 2019)
Warrant, dated March 9, 2016 issued to Sidney Taubenfeld (Filed With SEC on January 9, 2019)
Amendment No. 1, dated January 8, 2019 to Agreement and Plan of Merger (Filed With SEC on January 9, 2019)
Form of Tax Matters Agreement between Alliqua BioMedical, Inc. and AquaMed Technologies, Inc (Filed With SEC on January 9, 2019)
Amendment to Lease, dated as of February 23, 2007, by and between 2150 Cabot LLC and Hydrogel Design Systems, Inc (Filed With SEC on January 9, 2019)
Warrant, dated November 1, 2018, issued to Bernard Sucher, exercisable at $45.32 per Class A Unit (Filed With SEC on January 9, 2019)
Sublicense Agreement, dated as of January 12, 2018, by and between TO Pharmaceuticals USA LLC and Jay Pharma, Inc (Filed With SEC on January 9, 2019)
Consulting Agreement dated as of November 1, 2018 between TO Pharmaceuticals LLC and Broom Street Associates, LLC (Filed With SEC on January 9, 2019)
Management Consulting Agreement dated October 19, 2018 between TO Pharmaceutical LLC and Seth Yakatan (Filed With SEC on January 9, 2019)
Employment Agreement, dated as of March 9, 2016, by and between TO Pharmaceuticals LLC and Sidney Taubenfeld (Filed With SEC on January 9, 2019)
Letter Agreement, dated September 26, 2018, by and between T.O. Global LLC and TO Pharmaceuticals LLC (Filed With SEC on January 9, 2019)
Master Intercompany Services Agreement, dated as of January 1, 2018, by and among T.O. Global LLC, TO Holding Group LLC, Tikun Olam LLC, TO Pharmaceuticals LLC and Israel Liaison... (Filed With SEC on January 9, 2019)
Sublicense Agreement, dated as of January 12, 2018, by and between Tikun Olam IP Ltd. and Jay Pharma, Inc (Filed With SEC on January 9, 2019)
Amended and Restated Sublicense Agreement, dated as of January 12, 2018, by and between Tikun Olam IP Ltd. and Tikkun Pharma, Inc (Filed With SEC on January 9, 2019)
Third Amendment to Lease, dated as of February 27, 2009, by and between Exeter 2150 Cabot, L.P and Hydrogel Design Systems, Inc (Filed With SEC on January 9, 2019)
Amended and Restated Sublicense Agreement, dated as of January 12, 2018, by and between TO Pharmaceuticals USA LLC and Tikkun Pharma, Inc (Filed With SEC on January 9, 2019)
Amendment dated December 9, 2018, to License Agreement, dated as of April 13, 2017, by and between Tikun Olam Ltd. and Tikun Olam IP Ltd (Filed With SEC on January 9, 2019)
License Agreement, dated as of April 13, 2017, by and between Tikun Olam Ltd. and Tikun Olam IP Ltd (Filed With SEC on January 9, 2019)
Amendment dated December 9, 2018, to License Agreement, dated as of April 13, 2017, by and between Tikun Olam Ltd. and TO Pharmaceuticals USA LLC (Filed With SEC on January 9, 2019)
License Agreement, dated as of April 13, 2017, by and between Tikun Olam Ltd. and TO Pharmaceuticals USA LLC (Filed With SEC on January 9, 2019)
Fourth Amendment to Lease, dated as of July 24, 2013, by and between Exeter 2150 Cabot, L.P and Aquamed Technologies, Inc (Filed With SEC on January 9, 2019)
Assignment and Assumption of Lease Agreement, dated as of February 27, 2009, by and among Exeter 2150 Cabot, L.P, Hydrogel Design Systems, Inc. and Aquamed Technologies, Inc (Filed With SEC on January 9, 2019)
Warrant, dated November 1, 2018, issued to Bernard Sucher, exercisable at $15.11 per Class A Unit (Filed With SEC on January 9, 2019)